Evangelia Yannaki

8PUBLICATIONS
49CO-AUTHORS
Gene and molecular therapyRegenerative medicine (incl. stem cells)Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 24, 2026
In vivo HSPC gene therapy of hemoglobinopathies without drug selection of corrected cells.

|Jul 17, 2026
CD117 epitope-shielded hematopoietic stem cell transplantation with toxin-free conditioning and in vivo selection ameliorates a β-thalassemia model.

|Jun 04, 2026
Early Immunological Biomarkers for Personalized Treatment Selection in Severe COVID-19: Post Hoc Machine Learning Analysis of a Randomized Clinical Trial.

|May 09, 2025
Large-scale discovery of potent, compact and erythroid specific enhancers for gene therapy vectors.

Nikoletta Psatha, Pavel Sova, Grigorios Georgolopoulos

|Jul 17, 2023
SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial.

Anastasia Papadopoulou, George Karavalakis, Efthymia Papadopoulou

|Oct 18, 2021
Success Stories and Challenges Ahead in Hematopoietic Stem Cell Gene Therapy: Hemoglobinopathies as Disease Models.

Evangelia Yannaki, Nikoletta Psatha, Anastasia Papadopoulou

Pageof 2

Frequent Collaborators

4 joint publications

Anastasia Papadopoulou

3 joint publications

Nikoletta Psatha

3 joint publications

Grigorios Georgolopoulos

2 joint publications

Achilles Anagnostopoulos